Both public and private healthcare expenditures are coming under increasing pressure as costs rise as a fraction of GNP and new treatments outstrip patients’ ability to pay. The right pricing and market access strategy is essential to ensure patients can benefit from new therapies, as well as deliver commercial success for any new product launch. Irrespective of reimbursement status, it is vital to identify the best path to address price sensitivity and fast, reliable access routes to as many patients as possible. EVERSANA specializes in actionable solutions based on our deep understanding of pricing and access complexities presented by US markets of interest to EU clients. Our services include:
- 使用我们内部专有数据存储库（不断更新）的模拟数据进行价格敏感性分析
- 评估参考定价机制及其对不同市场的可能影响
- 分析不同定价结构（统一、线性、非线性）的可接受度
- 根据付款人顾问网络（基于概率的市场机遇评估）的意见，介绍可能的报销方案
- 提供以市场研究为重点的价格敏感性统计工具，获取实践层面的采用情况
- 测试患者负担能力计划的具体概念，以衡量在无报销市场的商业成功
We have successfully advised our clients across the Europe region and western markets with varied levels of public reimbursement coverage.